Different effects of amphetamine and amfonelic acid on peripheral and central catecholamine metabolism.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D015107:4-Butyrolactone / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002395:Catecholamines / Q000032:analysis / Q000378:metabolism*; D002421:Caudate Nucleus / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D005728:Ganglia, Sympathetic / Q000187:drug effects / Q000378:metabolism*; D006719:Homovanillic Acid / Q000032:analysis; D006801:Humans; D006948:Hyperkinesis; D007031:Hypothalamus / Q000378:metabolism; D009268:Nalidixic Acid / Q000031:analogs & derivatives; D009287:Naphthyridines / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000378:metabolism; D009830:Olfactory Bulb / Q000378:metabolism; D051381:Rats; D013239:Stereotyped Behavior
D002395:Catecholamines; D000697:Central Nervous System Stimulants; D009287:Naphthyridines; D015102:3,4-Dihydroxyphenylacetic Acid; D009268:Nalidixic Acid; D000661:Amphetamine; D015107:4-Butyrolactone; C006486:amfonelic acid; D003891:Desipramine; D006719:Homovanillic Acid